semaglutide pdufa FDA accepts filing application for oral 25 mg, which if approved, would be the first oral GLP-1 treatment for obesity FDA Clears Semaglutide For Cardiac

Under The Mental Health Parity and Addiction Equity Act, health insurers are required to cover substance use disorder treatment similar to how they would any physical condition

Moreno warns

Managing Side Effects During Hormonal Transition Side effects during Retatrutide treatment follow predictable patterns, though menopausal women may experience some unique considerations

doi:10.3322/caac.21834

This is known as emotional eating or stress eating , and is often done in response to feelings , as opposed to hunger

Bottom line is that GLP-1 drugs can support heart health, and evidence increasingly shows that benefit isnt solely explained by weight loss